Molecular basis of drug resistance in A/H1N1 virus

Journal of Chemical Information and Modeling

Volumn 52, Issue 10, 2012, Pages 2650-2656

  Vergara Jaque, Ariela ^a   Poblete, Horacio ^a   Lee, Eric H ^b   Schulten, Klaus ^b   González Nilo, Fernando ^c,e   Chipot, Christophe ^b,d  

^a UNIVERSIDAD DE TALCA   (Chile)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSIDAD ANDRÉS BELLO   (Chile)

^d NANCY UNIVERSITÉ   (France)

^e UNIVERSIDAD DE VALPARAÍSO   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; FREE ENERGY; MOLECULAR DYNAMICS;

ANTI-VIRAL DRUGS; BINDING AFFINITIES; CRYSTALLOGRAPHIC STRUCTURE; FREE ENERGY PERTURBATION; HUMAN INFLUENZA VIRUS; MOLECULAR BASIS; NEURAMINIDASE INHIBITORS; RELATIVE BINDING;

VIRUSES;

ANTIVIRUS AGENT; OSELTAMIVIR; SIALIDASE; VIRUS PROTEIN; ZANAMIVIR;

AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HUMAN; HYDROGEN BOND; INFLUENZA VIRUS A H1N1; MUTATION; STATIC ELECTRICITY; THERMODYNAMICS;

AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; COMPUTER SIMULATION; DRUG RESISTANCE, VIRAL; HUMANS; HYDROGEN BONDING; INFLUENZA A VIRUS, H1N1 SUBTYPE; MODELS, MOLECULAR; MUTATION; NEURAMINIDASE; OSELTAMIVIR; STATIC ELECTRICITY; THERMODYNAMICS; VIRAL PROTEINS; ZANAMIVIR;

EID: 84867774216     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci300343w     Document Type: Article

References (26)

1. Dawood, F. S.; Iuliano, A. D.; Reed, C.; Meltzer, M. I.; Shay, D. K.; Cheng, P. Y.; Bandaranayake, D.; Breiman, R. F.; Brooks, W. A.; Buchy, P.; Feikin, D. R.; Fowler, K. B.; Gordon, A.; Hien, N. T.; Horby, P.; Huang, Q. S.; Katz, M. A.; Krishnan, A.; Lal, R.; Montgomery, J. M.; Molbak, K.; Pebody, R.; Presanis, A. M.; Razuri, H.; Steens, A.; Tinoco, Y. O.; Wallinga, J.; Yu, H.; Vong, S.; Bresee, J.; Widdowson, M. A. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study Lancet Infect Dis. 2012, 12, 687-695
2. Air, G. M.; Laver, W. G. The neuraminidase of influenza virus Proteins. 1989, 6, 341-356
3. Von Itzstein, M. The war against influenza: discovery and development of sialidase inhibitors Nature Rev., Drug Discovery 2007, 6, 967-974
4. Morlighem, J.é.; Aoki, S.; Kishima, M.; Hanami, M.; Ogawa, C.; Jalloh, A.; Takahashi, Y.; Kawai, Y.; Saga, S.; Hayashi, E.; Ban, T.; Izumi, S.; Wada, A.; Mano, M.; Fukunaga, M.; Kijima, Y.; Shiomi, M.; Inoue, K.; Hata, T.; Koretsune, Y.; Kudo, K.; Himeno, Y.; Hirai, A.; Takahashi, K.; Sakai-Tagawa, Y.; Iwatsuki-Horimoto, K.; Kawaoka, Y.; Hayashizaki, Y.; Ishikawa, T. Mutation analysis of 2009 pandemic influenza A(H1N1) viruses collected in Japan during the peak phase of the pandemic PLoS One. 2011, 6, e18956
5. de Jong, M. D.; Tran, T. T.; Truong, H. K.; Vo, M. H.; Smith, G. J.; Nguyen, V. C.; Bach, V. C.; Phan, T. Q.; Do, Q. H.; Guan, Y.; Peiris, J. S.; Tran, T. H.; Farrar, J. Oseltamivir resistance during treatment of influenza A (H5N1) infection New Engl. J. Med. 2005, 353, 2667-2672
6. Collins, P. J.; Haire, L. F.; Lin, Y. P.; Liu, J.; Russell, R. J.; Walker, P. A.; Skehel, J. J.; Martin, S. R.; Hay, A. J.; Gamblin, S. J. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants Nature 2008, 453, 1258-1262
7. Gubareva, L. V.; Webster, R. G.; Hayden, F. G. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants Antimicrob. Agents Chemother. 2001, 45, 3403-3408
8. Kiso, M.; Mitamura, K.; Sakai-Tagawa, Y.; Shiraishi, K.; Kawakami, C.; Kimura, K.; Hayden, F. G.; Sugaya, N.; Kawaoka, Y. Resistant influenza A viruses in children treated with oseltamivir: descriptive study Lancet 2004, 364, 759-765
9. McKimm-Breschkin, J. L.; Selleck, P. W.; Usman, T. B.; Johnson, M. A. Reduced sensitivity of influenza A (H5N1) to oseltamivir Emerg. Infect. Dis. 2007, 13, 1354-1357
10. Malaisree, M.; Rungrotmongkol, T.; Nunthaboot, N.; Aruksakunwong, O.; Intharathep, P.; Decha, P.; Sompornpisut, P.; Hannongbua, S. Source of oseltamivir resistance in avian influenza H5N1 virus with the H274Y mutation Amino Acids. 2009, 37, 725-732
11. Cheng, L. S.; Amaro, R. E.; Xu, D.; Li, W. W.; Arzberger, P. W.; McCammon, J. A. Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase J. Med. Chem. 2008, 51, 3878-3894
12. Amaro, R. E.; Cheng, X.; Ivanov, I.; Xu, D.; McCammon, J. A. Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations J. Am. Chem. Soc. 2009, 131, 4702-4709
13. Lawrenz, M.; Baron, R.; McCammon, J. A. Independent-Trajectories Thermodynamic-Integration Free-Energy Changes for Biomolecular Systems: Determinants of H5N1 Avian Influenza Virus Neuraminidase Inhibition by Peramivir J. Chem. Theory Comput. 2009, 5, 1106-1116
14. Li, Q.; Qi, J.; Zhang, W.; Vavricka, C. J.; Shi, Y.; Wei, J.; Feng, E.; Shen, J.; Chen, J.; Liu, D.; He, J.; Yan, J.; Liu, H.; Jiang, H.; Teng, M.; Li, X.; Gao, G. F. The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site Nat. Struct. Mol. Biol. 2010, 17, 1266-1288
15. Le, L.; Lee, E.; Schulten, K.; Truong, T. N. Molecular modeling of swine influenza A/H1N1, Spanish H1N1, and avian H5N1 flu N1 neuraminidases bound to Tamiflu and Relenza PLoS Curr. 2009, 1, RRN1015
16. Malaisree, M.; Rungrotmongkol, T.; Decha, P.; Intharathep, P.; Aruksakunwong, O.; Hannongbua, S. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1 Proteins 2008, 71, 1908-1918
17. Russell, R. J.; Haire, L. F.; Stevens, D. J.; Collins, P. J.; Lin, Y. P.; Blackburn, G. M.; Hay, A. J.; Gamblin, S. J.; Skehel, J. J. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design Nature 2006, 443, 45-49
18. Liu, H.; Yao, X.; Wang, C.; Han, J. In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase Mol. Pharm. 2010, 7, 894-904
19. Yen, H. L.; Hoffmann, E.; Taylor, G.; Scholtissek, C.; Monto, A. S.; Webster, R. G.; Govorkova, E. A. Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses J. Virol. 2006, 80, 8787-8795
20. Le, L.; Lee, E. H.; Hardy, D. J.; Truong, T. N.; Schulten, K. Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases PLoS Comput Biol. 2010, 6, e1000939
21. Sung, J. C.; Van Wynsberghe, A. W.; Amaro, R. E.; Li, W. W.; McCammon, J. A. Role of secondary sialic acid binding sites in influenza N1 neuraminidase J. Am. Chem. Soc. 2010, 132, 2883-2885
22. Shobugawa, Y.; Saito, R.; Sato, I.; Kawashima, T.; Dapat, C.; Dapat, I. C.; Kondo, H.; Suzuki, Y.; Saito, K.; Suzuki, H. Clinical effectiveness of neuraminidase inhibitors-oseltamivir, zanamivir, laninamivir, and peramivir-for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan J. Infect. Chemother. 2012, 1-7
23. Zwanzig, R. W. High Temperature Equation of State by a Perturbation Method. I. Nonpolar Gases J. Chem. Phys. 1954, 22, 1420
24. Chipot, C.;; Pohorille, A. Free Energy Calculation s. Theory and Applications in Chemistry and Biology; Springer Series in Chemical Physics; Springer, 2007; p 86.
25. Bennett, C. H. Efficient estimation of free energy differences from Monte Carlo data J. Comp. Phys. 1976, 22, 245-268
26. Park, J. W.; Jo, W. H. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir J. Chem. Inf. Model. 2009, 49, 2735-2741